Evidence map›Paper›PMID 30530904›Full record

ArticleThe Journal of endocrinology2019

The depot-specific and essential roles of CBP/p300 in regulating adipose plasticity.

Maria Namwanje, Longhua Liu, Michelle Chan, Nikki Aaron, Michael J Kraakman, Li Qiang

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Maintenance of thermogenic adipose tissues despite loss of the H3K27 acetyltransferases p300 or CBP.American journal of physiology. Endocrinology and metabolism · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Epigenetic regulation of energy metabolism in obesity.Journal of molecular cell biology · 2021
    Review
  12. Article
  13. Identification ofFrontiers in pharmacology · 2021
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Maria NamwanjeNaomi Berrie Diabetes Center, Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Longhua LiuNaomi Berrie Diabetes Center, Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Michelle ChanDepartment of Biological Sciences, Columbia University, New York, New York, USA.
Nikki AaronNaomi Berrie Diabetes Center, Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Michael J KraakmanNaomi Berrie Diabetes Center, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Li QiangNaomi Berrie Diabetes Center, Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Columbia University · US

Funding

Translational Biomarker Analytical Core (TBAC)P30DK063608 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DOMENICO ACCILI · 2003 to 2026
$36.7M
RESEARCH TRAININGP30DK026687 · NIDDK · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI Anthony W Ferrante, DYMPNA GALLAGHER · 1986 to 2026
$33.0M
PPARgamma Deacetylation in the Restoration of Metabolic HomeostasisR01DK112943 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI QIANG, LI · 2018 to 2022
$2.4M
Brown Remodeling of White Adipose Tissue by PPARgamma DeacetylationR00DK097455 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI QIANG, LI · 2015 to 2017
$747k
Brown Remodeling of White Adipose Tissue by PPARgamma DeacetylationK99DK097455 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI QIANG, LI · 2013 to 2014
$180k
NIDDK NIH HHS K99 DK097455NIDDK NIH HHS P30 DK026687NIDDK NIH HHS P30 DK063608NIDDK NIH HHS R00 DK097455NIDDK NIH HHS R01 DK112943
6 · The paper itself

Abstract

Fat remodeling has been extensively explored through protein deacetylation, but not yet acetylation, as a viable therapeutic approach in the management of obesity and related metabolic disorders. Here, we investigated the functions of key acetyltransferases CBP/p300 in adipose remodeling and their physiological effects by generating adipose-specific deletion of CBP (Cbp-AKO), p300 (p300-AKO) and double-knockout (Cbp/p300-AKO) models. We demonstrated that Cbp-AKO exhibited marked brown remodeling of inguinal WAT (iWAT) but not epididymal WAT (eWAT) after cold exposure and that this pattern was exaggerated in diet-induced obesity (DIO). Despite this striking browning phenotype, loss of Cbp was insufficient to impact body weight or glucose tolerance. In contrast, ablation of p300 in adipose tissues had minimal effects on fat remodeling and adiposity. Surprisingly, double-knockout mice (Cbp/p300-AKO) developed severe lipodystrophy along with marked hepatic steatosis, hyperglycemia and hyperlipidemia. Furthermore, we demonstrated that pharmacological inhibition of Cbp and p300 activity suppressed adipogenesis. Collectively, these data suggest that (i) CBP, but not p300, has distinct functions in regulating fat remodeling and that this occurs in a depot-selective manner; (ii) brown remodeling occurs independently of the improvements in glucose metabolism and obesity and (iii) the combined roles of CBP and p300 are indispensable for normal adipose development.

Indexed as

Adiposity3T3-L1 CellsAdipogenesisAdipose Tissue, BrownAdipose Tissue, WhiteAnimalsDiet, High-FatGlucoseLipodystrophyMaleMiceMice, KnockoutObesityp300-CBP-Associated Factorp300-CBP Transcription FactorsThermogenesisGlucosep300-CBP-Associated Factorp300-CBP Transcription FactorsacetyltransferaseadipocytebrowningCbp/p300fat remodelinglipodystrophyobesity

Identifiers

PMID30530904
PMCPMC6813822
OpenAlexW2904193767

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.